Literature DB >> 21219427

Hyperbaric oxygen therapy improves health-related quality of life in patients with diabetes and chronic foot ulcer.

M Löndahl1, M Landin-Olsson, P Katzman.   

Abstract

AIMS: Adjunctive treatment with hyperbaric oxygen therapy has recently been shown to improve ulcer healing in patients with chronic diabetic foot ulcer. The aim of the present study is to evaluate whether hyperbaric oxygen therapy improves the health related quality of life in these patients.
METHODS: Prospective randomized placebo-controlled double-blinded study setting using SF-36.
RESULTS: A total of 75 patients were included in the study; 38 were randomized to hyperbaric oxygen therapy and 37 to placebo (hyperbaric air). The overall mean physical and mental summary scores for the entire study population at baseline were 29.6 ± 8.8 and 47.5 ± 12.4, respectively. There was a significant difference between baseline and 1 year follow-up responses to the mental summary score and two of the eight (SF-36) (?) domains in the -hyperbaric oxygen group, whereas no significant improvement of health related quality of life was seen in the placebo group. Comparing quality of life in patients who healed their ulcer (healers) with those who did not (non-healers), post-treatment levels of the mental health summary score, social functioning and role limitations due to physical and emotional health were significantly improved in healers. No differences were seen in any SF-36 (?) domain in non-healers.
CONCLUSIONS: Hyperbaric oxygen therapy improves long-term health related quality of life in patients with chronic diabetic foot ulcers, possibly attributable to better ulcer healing.
© 2011 The Authors. Diabetic Medicine © 2011 Diabetes UK.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21219427     DOI: 10.1111/j.1464-5491.2010.03185.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  16 in total

Review 1.  Unlocking mammalian regeneration through hypoxia inducible factor one alpha signaling.

Authors:  Kelsey G DeFrates; Daniela Franco; Ellen Heber-Katz; Phillip B Messersmith
Journal:  Biomaterials       Date:  2021-01-09       Impact factor: 12.479

2.  Hyperbaric oxygen preconditioning protects skin from UV-A damage.

Authors:  Ashley M Fuller; Charles Giardina; Lawrence E Hightower; George A Perdrizet; Cassandra A Tierney
Journal:  Cell Stress Chaperones       Date:  2012-08-03       Impact factor: 3.667

3.  Translation, cross-cultural adaptation and validation of the "Cardiff wound impact schedule," a wound-specific quality of life instrument, to the native Spanish of Mexican patients.

Authors:  Adriana Lozano-Platonoff; Jose Contreras-Ruiz; Judith Dominguez-Cherit; Andrea Cardenas-Sanchez; Valeria Alvarez-Rivero; Joel A Martínez-Regalado
Journal:  Int Wound J       Date:  2019-11-11       Impact factor: 3.315

Review 4.  Hyperbaric oxygen therapy for chronic wounds.

Authors:  Peter Kranke; Michael H Bennett; Marrissa Martyn-St James; Alexander Schnabel; Sebastian E Debus; Stephanie Weibel
Journal:  Cochrane Database Syst Rev       Date:  2015-06-24

Review 5.  What is the role of hyperbaric oxygen in the management of diabetic foot disease?

Authors:  Magnus Löndahl; Katarina Fagher; Per Katzman
Journal:  Curr Diab Rep       Date:  2011-08       Impact factor: 4.810

6.  Hyperbaric oxygen therapy (HBOT) suppresses biomarkers of cell stress and kidney injury in diabetic mice.

Authors:  Rajeev Verma; Avijeet Chopra; Charles Giardina; Venkata Sabbisetti; Joan A Smyth; Lawrence E Hightower; George A Perdrizet
Journal:  Cell Stress Chaperones       Date:  2015-02-04       Impact factor: 3.667

Review 7.  Diabetic foot ulcers treated with hyperbaric oxygen therapy: a review of the literature.

Authors:  Alexandra J Bishop; Elizabeth Mudge
Journal:  Int Wound J       Date:  2012-07-02       Impact factor: 3.315

Review 8.  Hyperbaric Oxygen Therapy for the Treatment of Diabetic Foot Ulcers: A Health Technology Assessment.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2017-05-12

9.  Adjunct methods of the standard diabetic foot ulceration therapy.

Authors:  Dariusz Waniczek; Andrzej Kozowicz; Małgorzata Muc-Wierzgoń; Teresa Kokot; Elżbieta Swiętochowska; Ewa Nowakowska-Zajdel
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-13       Impact factor: 2.629

10.  IGF-1 Increases with Hyperbaric Oxygen Therapy and Promotes Wound Healing in Diabetic Foot Ulcers.

Authors:  Figen Aydin; Ahmet Kaya; Levent Karapinar; Mert Kumbaraci; Ahmet Imerci; Hasan Karapinar; Cengiz Karakuzu; Mustafa Incesu
Journal:  J Diabetes Res       Date:  2013-02-26       Impact factor: 4.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.